SCHEMBL1608162

SCHEMBL1608162

COc1cccc(Cn2ccc3cnc(C(=O)NO)cc32)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 9/20 0.55
HDAC8 Q9BY41 8/20 0.55
HDAC1 Q13547 8/20 0.55
HDAC2 Q92769 6/20 0.55
HDAC10 Q969S8 6/20 0.55
HDAC3 O15379 5/20 0.55
HDAC11 Q96DB2 3/20 0.53
HDAC7 Q8WUI4 3/20 0.53
HDAC9 Q9UKV0 3/20 0.53
HDAC4 P56524 2/20 0.53
HDAC5 Q9UQL6 2/20 0.53
NCOR2 Q9Y618 1/20 0.53
JAK2 O60674 2/20 0.48
LPO P22079 3/20 0.47
PTGER4 P35408 1/20 0.45
PTGER2 P43116 1/20 0.45
SYK P43405 1/20 0.45
MMP13 P45452 1/20 0.44
SLC2A1 P11166 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608524 0.88 HDAC6 (0.67) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1608516 0.86 HDAC8 (0.44) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1608410 0.86 HDAC6 (0.51) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1607598 0.84 HDAC6 (0.53) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1608559 0.84 HDAC6 (0.46) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1609287 0.84 MAOB (0.56) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1607519 0.82 ADRA1D (0.40) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1608298 0.82 HDAC8 (0.78) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1608885 0.82 HDAC6 (0.48) HDAC6HDAC8HDAC1HDAC2HDAC10
SCHEMBL1607541 0.82 HDAC6 (0.51) HDAC6HDAC8HDAC1HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE PHARMACYCLICS LLC 2015-11-12 US disclosed
US-8906954-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2014-12-09 US disclosed
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2014-01-02 US disclosed
US-8466193-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2013-06-18 US disclosed
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS LLC 2011-04-07 US disclosed
EP-2265590-A2 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2010-12-29 EP disclosed
WO-2009129335-A2 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2009-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC6 11/4885HDAC8 1/4885HDAC1 2/4885
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE HDAC8, HDAC1, HDAC5 HDAC6 11/4885HDAC8 1/4885HDAC1 2/4885
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC6 11/4885HDAC8 1/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.